TipRanks
Molecular Partners AG (DE:6ML)
FRANKFURT:6ML

Compare Molecular Partners AG (6ML) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
€3.60
€144.58M
-2.45
17.80%
―
Basilea Pharmaceutica
CHF63.30
CHF834.11M
15.68
38.59%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF5.34
CHF1.22B
-3.40
-1.81%
1 Buy
1 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF12.60
CHF173.73M
-5.97
-36.36%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF15.56
CHF232.55M
-6.63
47.08%
―
MindMaze Therapeutics Holding SA
CHF0.19
CHF26.24M
-2.13
-95.82%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:6ML
Molecular Partners AG
3.54
0.42
13.64%
CH:BSLN
Basilea Pharmaceutica
66.80
18.00
36.89%
CH:IDIA
Idorsia Ltd
4.46
0.10
2.37%
CH:NWRN
Newron Pharmaceuticals SpA
8.12
-5.98
-42.41%
CH:SANN
Santhera Pharmaceuticals Holding
15.12
4.62
44.00%
CH:MMTX
MindMaze Therapeutics Holding SA
0.14
-3.24
-95.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts